Francois Bethoux, MD

Appointed
2001

Education & Fellowships

Fellowship - Cleveland Clinic
Neuroimmunology
Cleveland, OH United States
2000

Fellowship - MetroHealth Medical Center
Research Fellow-Funct. Elect.
Cleveland, OH
1995

Graduate School - University of Burgundy
Diploma of Special Studies in
Dijon, France,
1994

Residency - University Hospitals of Saint Etienne
PM & R
France
1994

Internship - University Hospitals of Lyon
Internal Medicine
69002 Lyon,,
1990

Medical Education - Alexis Carrel Medical School
MD
Lyon, France, France
1988

Certifications

• Physical Medicine & Rehabilitation

Specialty Interests

neuro-rehabilitation, spasticity management

Awards & Honors

• Principal Investigator, “Efficacy Of  A Hip  Flexion Assist Orthosis In Ambulatory Multiple Sclerosis Patients,” National Multiple Sclerosis Society grant, 2010-2012
• Principal Investigator, “Randomized, controlled trial of rehabilitation following acute relapses of MS,” study funded by the National Multiple Sclerosis Society, 2000-2003

Innovations & Patents

• Participated in the design and testing of a new leg brace (hip flexion assist orthosis) in patients with multiple sclerosis. A pilot study of the brace was funded by the National Multiple Sclerosis Society. The results of the study were accepted for publication in the Archives of Physical Medicine and Rehabilitation. Patients with hip flexor weakness using the brace have experienced significant improvement of walking performance and leg strength.

See publications for Francois Bethoux, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/13/2023, Dr. Bethoux has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Bethoux receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Royal Clinics

Royalty Payments. Dr. Bethoux receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• Springer
• Biogen Idec, Inc.
• Qr8 Health, Inc.

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Bethoux may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

• Qr8 Health, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.